Download Mendeleytrans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo.
Aron, Z.D., Mehrani, A., Hoffer, E.D., Connolly, K.L., Srinivas, P., Torhan, M.C., Alumasa, J.N., Cabrera, M., Hosangadi, D., Barbor, J.S., Cardinale, S.C., Kwasny, S.M., Morin, L.R., Butler, M.M., Opperman, T.J., Bowlin, T.L., Jerse, A., Stagg, S.M., Dunham, C.M., Keiler, K.C.(2021) Nat Commun 12: 1799-1799
- PubMed: 33741965
- DOI: https://doi.org/10.1038/s41467-021-22012-7
- Primary Citation of Related Structures:
6OM6 - PubMed Abstract:
Bacterial ribosome rescue pathways that remove ribosomes stalled on mRNAs during translation have been proposed as novel antibiotic targets because they are essential in bacteria and are not conserved in humans. We previously reported the discovery of a family of acylaminooxadiazoles that selectively inhibit trans-translation, the main ribosome rescue pathway in bacteria. Here, we report optimization of the pharmacokinetic and antibiotic properties of the acylaminooxadiazoles, producing MBX-4132, which clears multiple-drug resistant Neisseria gonorrhoeae infection in mice after a single oral dose. Single particle cryogenic-EM studies of non-stop ribosomes show that acylaminooxadiazoles bind to a unique site near the peptidyl-transfer center and significantly alter the conformation of ribosomal protein bL27, suggesting a novel mechanism for specific inhibition of trans-translation by these molecules. These results show that trans-translation is a viable therapeutic target and reveal a new conformation within the bacterial ribosome that may be critical for ribosome rescue pathways.
Organizational Affiliation:
Microbiotix, Inc. One Innovation Dr., Worcester, MA, USA.
